$NERV
Minerva Neurosciences Inc
PRICE
$6.4 ▼-0.156%
Extented Hours
VOLUME
12,556
DAY RANGE
6.08 - 6.71
52 WEEK
1.26 - 14.7
Join Discuss about NERV with like-minded investors
@soheil.n #StockTraders.NET
2nd leg to the upside for $NERV? > @Math said: second leg is near imo, will see
109 Replies 13 👍 11 🔥
@singletary #StockTraders.NET
$NERV same kinda play as $ISEE no volume at all but at key lvl
107 Replies 10 👍 8 🔥
@danny4259 #StockTraders.NET
were you short $NERV overnight or are the green arrows buy orders? > @singletary said:
94 Replies 10 👍 15 🔥
@soheil.n #StockTraders.NET
probably going red today...no borrows > @singletary said: $NERV fuckin sick one hope yall doing well
40 Replies 14 👍 15 🔥
@BrittJ #StockTraders.NET
Nice alert!! > @singletary said: $NERV clearout incoming?
140 Replies 15 👍 10 🔥
Key Metrics
Market Cap
46.86 M
Beta
0
Avg. Volume
18.81 K
Shares Outstanding
6.99 M
Yield
0%
Public Float
0
Next Earnings Date
2023-11-09
Next Dividend Date
Company Information
minerva neurosciences, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases. its lead product candidate is roluperidone, which is in phase iii clinical trial, a compound for the treatment of schizophrenia. the company is also developing seltorexant that has completed phase iib clinical trial for treating insomnia and major depressive disorders; and min-301, which is in pre-clinical trial, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of parkinson's disease. minerva neurosciences, inc. has a license agreement with mitsubishi tanabe pharma corporation for the development and commercialization of the roluperidone worldwide, excluding asia; and co-development and license agreement with janssen pharmaceutica, n.v. for the development of seltorexant. the company was formerly known as cyrenaic pharmaceuticals, inc. and changed its
CEO: Remy Luthringer
Website: http://minervaneurosciences.com/
HQ: 1601 Trapelo Rd Ste 286 Waltham, 02451-7337 Massachusetts
Related News